Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: The alternative dosing for outpatient treatment (ADOPT) trial

David P. Steensma, Maria R. Baer, James L. Slack, Rena Buckstein, Lucy A. Godley, Guillermo Garcia-Manero, Maher Albitar, Julie S. Larsen, Sujata Arora, Michael T. Cullen, Hagop Kantarjian

Research output: Contribution to journalArticle

234 Scopus citations

Fingerprint Dive into the research topics of 'Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: The alternative dosing for outpatient treatment (ADOPT) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences